No abstract available.
Acupuncture* ; Lipolysis*

OBJECTIVE: Catecholamine play a central role in the regulation of energy expenditure, in part by stimulating lipid mobilization through lipolysis in fat cells. The beta-2 adrenergic receptor(BAR-2) is a major lipolytic receptor in human fat cells. A recent study has shown that common polymorphisms occuring at codon 16 and 27 of the BAR-2 gene are significantly associated with obesity and lypolytic BAR-2 function in adipose tissue. We investigated whether the previously described human BAR-2 gene polymorphisms are associated with obesiy and NIDDM in Koreans. METHODS: All subjests were divided into two groups, non-obese and obese group, according to their body mass index. And their clinical characteristics were evaluated. The BAR-2 gene polymorphisms were analyzed by PCR-RFLP in 89 nondiabetics and 106 patients with NIDDM. RESULTS: When the allele frequency of BAR-2 gene polymorphisms was compared with that of western people, there was a significant difference. In our study, there was no significant difference in the allele frequency of BAR-2 gene polymorphisms at codons 16 and 27 between nonobese and obese group both nondiabetics and NIDDM subjects. The frequency of Glu27 homozygotes was very rare(1.1%). Body mass index(BMI), waist-hip ratio(WHR), and serum glucose and insulin secretion of the nondiabetics with polymorphism of codon 16 or codon 27 did not differ from those of the subjects without the polymorphisms. In NIDDM group, the Gly16 homozygotes had a lower BMI than Arg16 homozygotes without any difference in WHR and the other laboratory parameters. Neither clinical or laboratory parameters of the diabetics with the polymorphism at codon 27 differ from those of subjectes without the polymorphism. CONCLUSION: These findings suggest that the genetic variability in the human BAR-2 gene is not a major determinant for the development of obesity and NIDDM in Koreans.
Adipocytes ; Adipose Tissue ; Blood Glucose ; Body Mass Index ; Codon ; Diabetes Mellitus, Type 2 ; Energy Metabolism ; Gene Frequency ; Homozygote ; Humans ; Insulin ; Lipid Mobilization ; Lipolysis ; Obesity* ; Receptors, Adrenergic, beta-2*

BACKGROUND: Lipomas are benign neoplasms composed of mature fat cells. Current treatments are invasive and carry the risk of scarring. For this reason, phosphatidylcholine (PPC) formula has been widely used to treat areas of localized fat accumulation. However, there are few reports on injection lipolysis with injection of PPC formula. OBJECTIVE: The purpose of this study was to investigate whether injection lipolysis with PPC formula is an effective therapeutic option for patients with lipoma. METHODS: Twenty-two lipomas in 7 patients were included. Three sessions at intervals of 6 to 8 weeks were done. Sonographic measurements of lipoma size were repeated before each session. Any side-effects and the patients' satisfaction were noted. In one lipoma, histological changes after lipolysis were described. RESULTS: After three sessions, a significant reduction in lipoma size of 47.4% was achieved. Histology showed a fibrosis with loss of adipocytes. Inflammation occurred in one case, so the patient was excluded from this study. Transient burning sensation and swelling at the injection site were the most common adverse effects. No severe side-effects or systemic reactions were observed. CONCLUSION: Treatment of lipoma with PPC formula has the potential to be a patient-friendly and well-tolerated therapy that can achieve cosmetically pleasing treatment outcomes.
Adipocytes ; Burns ; Cicatrix ; Fibrosis ; Humans ; Inflammation ; Lipolysis ; Lipoma ; Phosphatidylcholines ; Sensation

Increased intracellular levels of Ca²⁺ are generally thought to negatively regulate lipolysis in mature adipocytes, whereas store-operated Ca²⁺ entry was recently reported to facilitate lipolysis and attenuate lipotoxicity by inducing lipophagy. Transient receptor potential mucolipin1 (TRPML1), a Ca²⁺-permeable non-selective cation channel, is mainly expressed on the lysosomal membrane and plays key roles in lysosomal homeostasis and membrane trafficking. However, the roles of TRPML1 in lipolysis remains unclear. In this study, we examined whether the channel function of TRPML1 induces lipolysis in mature adipocytes. We found that treatment of mature adipocytes with ML-SA1, a specific agonist of TRPML1, solely upregulated extracellular glycerol release, but not to the same extent as isoproterenol. In addition, knockdown of TRPML1 in mature adipocytes significantly reduced autophagic flux, regardless of ML-SA1 treatment. Our findings demonstrate that the channel function of TRPML1 partially contributes to lipid metabolism and autophagic membrane trafficking, suggesting that TRPML1, particularly the channel function of TRPML1, is as therapeutic target molecule for treating obesity.
Adipocytes ; Glycerol ; Homeostasis ; Isoproterenol ; Lipid Metabolism ; Lipolysis ; Membranes ; Obesity

BACKGROUND: An alpha2-adrenergic receptor (alpha2-AR, ADRA2) mediates induction of hypotension and inhibition of lipolysis and insulin secretion. We evaluated whether single nucleotide polymorphisms (SNPs) of alpha2A (ADRA2A), alpha2B (ADRA2B), and alpha2C (ADRA2C) adrenergic receptors are associated with cerebral white matter lesion (cWML). METHODS: Total 336 study subjects who had no stroke were enrolled in this study. The Indices of cWML include total WML (TWML), periventricular WML (PVWML), and subcortical WML (SCWML) on brain fluid-attenuated inversion recovery (FLAIR) image. Common genetic variants of ADRA2A (1780G>A), ADRA2B (Ins/Del301-303), and ADRA2C (Ins/Del322-325) were examined. RESULTS: Among 336 study subjects, cWML was found in 66 patients (20%). In multivariate analysis, there were no significant effects of all tested ADRA2 polymorphisms on TWML. Significant association of ADRA2A 1780 AA genotype was found in PVWML (OR: 3.368, 95% CIs: 1.280-8.865, adjusted p-value after false discovery rate (FDR) correction=0.014) but not SCWML. CONCLUSION: Although SNPs of three ADRA2 subtypes failed to reach a significance in overall risk for cWML, the ADRA2A 1780G>A polymorphism may be associated with development of PVWML.
Brain ; Genotype ; Humans ; Hypotension ; Insulin ; Lipolysis ; Multivariate Analysis ; Polymorphism, Single Nucleotide ; Receptors, Adrenergic ; Stroke

Many treatment modalities have been developed for axillary osmidrosis. It is well known that the surgical treatment has the best results. However, there is a high possibility of side effects. The 1,444-nm lipolysis laser has been recently introduced to remove the apocrine glands. So far, subdermal coagulation treatment with a 1,444-nm Nd:YAG laser may be the least invasive and most effective therapy for axillary osmidrosis. However, according to our previous experience, the recurrence rate was 20%~30%. This emphasizes the need for combination of surgical method and non-surgical method and we combined subcutaneous tissue removal and photothermocoagulation with a 1,444-nm Nd:YAG laser. Three patients for bilateral axillary osmidrosis were enrolled. After an incision of about one-third the length of the widest transverse diameter, the apocrine glands were separated from the skin. And then apocrine glands within the marked area were destroyed by irradiation with a 1,444-nm Nd:YAG laser thereafter. All patients exhibited no relapse of axillary osmidrosis and were satisfied with the treatment results. A combination of subcutaneous tissue removal and Interstitial laser photothermocoagulation with a 1,444-nm Nd:YAG laser could be an effective treatment for mild to moderate axillary osmidrosis.
Apocrine Glands ; Humans ; Lipolysis ; Recurrence ; Skin ; Subcutaneous Tissue* ; Surgical Procedures, Minimally Invasive*

Before the development of dapsone the standard remedy for Hansen's disease was the chaulmoogra oil. The oil was first introduced to western physicians in the 1850's by Dr. Fredric J. Mouat, the British physician, in India. Around 1900, leprosaria in the Hawaiian Islands and at Carville, Louisiana, adopted the chaulmoogra oil as their main treatment. But the oil has been traditionally treated as a drug for Hansen's disease in India and China since 2000 years before. Although the mechanism of action is not known, the lipolysis hypothesis or chemotatic theory resulted from counter irritation was suggested. Since the development of sulfone in 1947, the oil has not been used anymore as antileprosy medication. However, recent reports about the effect of the oil on wound healing in Hansen's disease and diabetes provided us with the possibility of the reappraisal of the chaulmoogra oil. We performed this study to determine the effect of the chaulmoogra oil on wound healing in Hansen's disease patients still having neuropathic foot ulcers and ulcerations of paraffinoma as sequelae.
China ; Dapsone ; Foot Ulcer ; Humans ; India ; Islands ; Leprosy ; Lipolysis ; Louisiana ; Ulcer ; Wound Healing

A concern about drug therapy for obesity has been increased with launching of new anti-obesity drug in Korea. Subcutaneous injection of aminophylline was used for regional lipolysis, but its effectiveness and safety are controversial. The purpose of this study is to investigate the effects of aminophylline on lipolytic activity and cytotoxic effect in adipocytes. Preadipocytes obtained from human breast fat tissue were cultured in monolayer culture system. Cells were treated with media added 1, 5, 10, 15, 25 mM aminophylline concentrations, respectively. Cytotoxicity was measured by XTT colorimetric assay and cell count. The lipolytic activity was measured by enzymatic autoanalyzed system. At above 15mM of aminophylline concentration, preadipocyte and adipocyte markedly presented cytotoxic effects. In proportion to concentration, lipolytic activity was increased and maximal lipolytic activity without marked cytotoxicity was measured at 10mM of aminophylline concentration.
Adipocytes* ; Aminophylline* ; Breast ; Cell Count ; Drug Therapy ; Humans ; Injections, Subcutaneous ; Korea ; Lipolysis ; Obesity

Rho iso-alpha acids-rich extract (RIAA) from Humulus lupulus (hops) and proanthocyanidins-rich extracts (PAC) from Acacia nilotica exert anti-inflammatory and anti-diabetic activity in vitro and in vivo. We hypothesized that a combination of these two extracts would exert enhanced effects in vitro on inflammatory markers and insulin signaling, and on nonfasting glucose and insulin in db/db mice. Over 49 tested combinations, RIAA:PAC at 5:1 (6.25 microg/mL) exhibited the greatest reductions in TNFalpha-stimulated lipolysis and IL-6 release in 3T3-L1 adipocytes, comparable to 5 microg/mL troglitazone. Pretreatment of 3T3-L1 adipocytes with this combination (5 microg/mL) also led to a 3-fold increase in insulin-stimulated glucose uptake that was comparable to 5 microg/mL pioglitazone or 901 microg/mL aspirin. Finally, db/db mice fed with RIAA:PAC at 5:1 (100 mg/kg) for 7 days resulted in 22% decrease in nonfasting glucose and 19% decrease in insulin that was comparable to 0.5 mg/kg rosiglitazone and better than 100 mg/kg metformin. RIAA:PAC mixture may have the potential to be an alternative when conventional therapy is undesirable or ineffective, and future research exploring its long-term clinical application is warranted.
Acacia ; Adipocytes ; Animals ; Aspirin ; Chromans ; Glucose ; Humulus ; Insulin ; Insulin Resistance ; Interleukin-6 ; Lipolysis ; Metformin ; Mice ; Thiazolidinediones

The obesity induce not only physical problem, but psychological and emotional problem. The focus of body contour procedures is the body's unequal distribution of fat. Aminophylline is a 2-adrenaline agonist, an adenosine inhibitor, and a phosphodiesterase inhibitor. It activates c-AMP, and facilitates lipolysis. Forty rats were used to study the effect of aminophylline subcutaneous injection, and divided in four groups, In the control group(n=10), saline was injected to subcutaneous fat of the abdomen. In the experimental group, aminophylline 50 mg/kg(n=10), 100 mg/kg(n=10) and 200 mg/kg(n=10) were injected. The injection was done daily for three weeks. The four groups were measured by weight, abdomen circumference, biochemistry, and histopathological test. There were no difference among the four groups. In conclusion, aminophylline subcutaneous injection is not effective in the reduction of regional and systemic fat.
Abdomen ; Adenosine ; Aminophylline* ; Animals ; Biochemistry ; Injections, Subcutaneous ; Lipolysis ; Obesity ; Rats ; Subcutaneous Fat*